Twist Bioscience Corp (NASDAQ:TWST) Q1 2023 Earnings Conference Call February 3, 2023 8:00 AM ET
Company Participants
Angela Bitting - Chief ESG Officer & SVP, Corporate Affairs
Emily Leproust - Co-Founder, Chairman & CEO
James Thorburn - CFO
Conference Call Participants
Poon Mah - Cowen and Company
Luke Sergott - Barclays Bank
Matthew Larew - William Blair & Company
Vijay Kumar - Evercore ISI
Puneet Souda - SVB Securities
Noah Burhance - JPMorgan Chase & Co.
Operator
Welcome to Twist Bioscience's Fiscal 2023 First Quarter Financial Results Conference Call. [Operator Instructions].
I would now like to turn the call over to Angela Bitting, Senior Vice President of Corporate Affairs and Chief ESG Officer.
Angela Bitting
Thank you, operator. Good morning, everyone. I would like to thank all of you for joining us today for the Twist Bioscience conference call to review our fiscal 2023 first quarter financial results and business progress. We issued our financial results release this morning, which is available at our website at www.twistbioscience.com.
With me on today's call are Dr. Emily Leproust, CEO and Co-Founder of Twist; and Jim Thorburn, CFO of Twist. Emily will begin with a review of our recent progress on Twist businesses. Jim will report on our financial and operational performance. Emily will come back to discuss our upcoming milestones and direction, and then we'll open the call for questions. (Operator Instructions) As a reminder, this call is being recorded. The audio portion will be archived in the Investors section of our website and will be available for 2 weeks.
During today's presentation, we will be making forward-looking statements within the meaning of the U.S. Federal Securities Laws. Forward-looking statements generally relate to future events to future events or future financial or operating performance. Our expectations and beliefs regarding these matters may not materialize and actual results and financial periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected. These risks include those set forth in the press release we issued earlier today as well as those more fully described in our filings with the Securities and Exchange Commission. The forward-looking statements in this presentation are based on information available to us as of the date hereof, and we disclaim any obligation to update any forward-looking statements, except as required by law.
With that, I will now turn the call over to our Chief Executive Officer and Co-Founder, Dr. Emily Leproust.